Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Nov 5, 2015 · 10-Q · 36 days after period end · 0001564590-15-009495
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$51.94M | -$29.23M | -$42.03M | -$49.55M |
| EPS Diluted | -$1.25 | -$0.71 | -$1.24 | -$2.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 5, 2015 · 36 d after period end
